Vitamin K2 to prevent steroid bone loss in children
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests whether vitamin K2 can help prevent bone loss caused by steroid treatment in children with nephrotic syndrome. If your child meets the requirements, taking vitamin K2 may protect their bones while they receive steroids.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a child under 16 years old with nephrotic syndrome.
- You are taking glucocorticoids (steroids) for the first time and have been on them for more than 6 months.
- Your vitamin D level is at least 30 ng/mL (75 nmol/L).
- You do not have kidney problems, conditions that affect vitamin absorption (like celiac disease), or a history of bone fractures or bleeding disorders.
- Your nephrotic syndrome is not due to a known genetic cause.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether vitamin K2 can help people with chronic kidney disease (kidney damage that lasts months or longer), especially those with higher protein levels in the urine. It compares vitamin K2 use in a specific group and watches kidney-related health outcomes and safety.
This study tests if applying a vitamin K2 gel directly into the tooth socket after extraction can help rebuild healthy bone faster. It is for people who need to have a single-rooted lower tooth removed.
This study tests whether taking vitamin K2 can help people with low bone density (osteopenia or osteoporosis) who have a specific change in the VDR gene. If you have this gene change, vitamin K2 may work better for you than standard supplements.
This study tests whether taking vitamin D3 and K2 supplements can improve health in military healthcare workers who have low vitamin D levels. If you qualify, you will stop any current vitamin D or K supplements and take the study supplement for 4.5 months.
This trial tests whether rituximab works as well as mycophenolate in children whose nephrotic syndrome (kidney condition) comes back when steroid medicines are reduced. It aims to find the safest and most effective option during a relapse.
This trial compares two types of vitamin D—one is plain vitamin D2, the other is vitamin D2 plus a more active form (calcitriol)—to see which works better for children with liver problems and low vitamin D levels.
Hear when a new Pediatrics Nephrology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.